Clinical Features	Time to Death		AGE		GENDER		KARNOFSKY.PERFORMANCE.SCORE		DISTANT.METASTASIS		LYMPH.NODE.METASTASIS		TUMOR.STAGECODE		NEOPLASM.DISEASESTAGE	
	nMutated (%)	nWild-Type	logrank test_P	logrank test_Q	t-test_P	t-test_Q	Fisher's exact test_P	Fisher's exact test_Q	t-test_P	t-test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	t-test_P	t-test_Q	Fisher's exact test_P	Fisher's exact test_Q
PBRM1	107 (37%)	186	0.53349	1	0.81311	1	0.30948	1	0.4287	1	0.59296	1	0.41338	1	NA	NA	0.93935	1
SV2C	3 (1%)	290	0.73052	1	0.020511	1	1	1	NA	NA	1	1	0.20545	1	NA	NA	1	1
VHL	138 (47%)	155	0.668	1	0.03006	1	0.17649	1	0.35871	1	1	1	0.49081	1	NA	NA	0.14504	1
BAP1	27 (9%)	266	0.01358	0.76	0.74207	1	0.0023782	0.14	NA	NA	0.0041109	0.238	0.10776	1	NA	NA	0.00029109	0.018
SETD2	34 (12%)	259	0.76246	1	0.099415	1	0.18058	1	NA	NA	0.10113	1	0.7202	1	NA	NA	0.05908	1
KDM5C	18 (6%)	275	0.080341	1	0.20614	1	0.0048565	0.277	NA	NA	1	1	0.74124	1	NA	NA	0.85697	1
TP53	6 (2%)	287	0.0003537	0.0216	0.25945	1	0.18769	1	NA	NA	0.57895	1	0.16906	1	NA	NA	0.022121	1
PTEN	9 (3%)	284	0.7694	1	0.21907	1	0.5035	1	NA	NA	0.61301	1	0.029887	1	NA	NA	0.22637	1
EBPL	6 (2%)	287	0.4799	1	0.52653	1	0.0016133	0.0968	NA	NA	1	1	0.038351	1	NA	NA	0.075753	1
TOR1A	3 (1%)	290	0.053193	1	0.70446	1	1	1	NA	NA	1	1	0.056203	1	NA	NA	1	1